Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
IP
DRUG
4 trials
Sponsors
Clinical Research Center for Solid Tumor, Korea
, National Cancer Center, Korea
, Vedic Lifesciences Pvt. Ltd.
, Nurix Therapeutics, Inc.
Conditions
Deficiency Growth Hormone
Healthy Volunteers
Non Small Cell Lung Cancer
Small Cell Lung Cancer
Phase 1
A Food-Effect, Drug-Drug Interaction, and Pharmacokinetics Study of NX-5948 in Healthy Adult Subjects
Completed
NCT06593457
Nurix Therapeutics, Inc.
Healthy Volunteers
Start: 2024-08-20
End: 2024-11-14
Updated: 2025-03-14
Phase 2
Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV
Completed
NCT01003964
National Cancer Center, Korea
Non Small Cell Lung Cancer
Start: 2009-02-28
End: 2015-06-30
Updated: 2022-04-12
Phase 3
A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer
Completed
NCT00349492
Clinical Research Center for Solid Tumor, Korea
Small Cell Lung Cancer
Start: 2006-06-30
End: 2013-10-31
Target: 372
Updated: 2013-12-04
Unknown Phase
Assessment of the Acute Effect of IP
Completed
NCT03658187
Vedic Lifesciences Pvt. Ltd.
Deficiency Growth Hormone
Start: 2018-07-19
End: 2019-01-25
Updated: 2019-05-31
Related Papers
PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer.
2016-08-12
31 citations